Oppenheimer Asset Management Inc. Biolife Solutions Inc Transaction History
Oppenheimer Asset Management Inc.
- $7.78 Billion
- Q1 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 16,935 shares of BLFS stock, worth $364,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,935
Previous 16,763
1.03%
Holding current value
$364,102
Previous $435,000
11.26%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BLFS
# of Institutions
202Shares Held
48.8MCall Options Held
2.5KPut Options Held
182K-
Casdin Capital, LLC New York, NY8.71MShares$187 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$118 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$76.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$60.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$33 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $918M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...